Relay Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$12.76

+0.25 (+2.00%)

As of May 9, 1:34 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +411.2% upside

Low Target $47.67

Average Target $65.23

High Target $99.61

Current Price $12.76

Current
$12.76

Target
$65.23

$47.67 $65.23 avg $99.61

Scenario Analysis

Bear Case

$47.67

273.6%

Low target

Base Case

$65.23

+411.2%

Avg target

Bull Case

$99.61

+680.6%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$17.32

-26.3% from high

52-Week Low

$2.67

+377.9% from low

Target vs 52W High

$65.23

+276.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%